Pathwork Diagnostics, Novartis partnership
This article was originally published in The Gray Sheet
Executive Summary
Pathwork Diagnostics will work with Novartis to discover "clinically meaningful biomarker signatures" that can be used to develop diagnostics for a variety of cancers. Financial terms were not disclosed, but the deal gives both parties the rights to develop and commercialize diagnostic products developed from their partnership. Pathwork is based in Redwood City, Calif